排序方式: 共有1条查询结果,搜索用时 0 毫秒
1
1.
S. Raj Sundaraj MBBS FANZCA FFPMANZCA FIPP CIME ; Paul Ponciano MD ; Charlotte Johnstone MBBS FANZCA FFPMANZCA ; Faiz Noore MBBS FANZCP FFPMANZCA ; Maria Castro RN CNC 《Pain practice》2004,4(3):229-234
Abstract: Chronic refractory daily headache is a relatively common problem in the Australian population. Several million working hours per year are lost due to this illness. Generally not responding to conventional therapies. We treated 22 such patients diagnosed as severe refractory migraine and/or mixed tension headache at our multidisciplinary pain management center. Before inclusion to our study, they received maximal medical management, which included cognitive behavior therapy, but failed to respond. These patients received between 30 and 100 units of botulinum toxin type A. Our study showed 84% (19 of 22) achieved significant improvement in their pain complaint. There was significant reduction of medications particularly opioids. The duration of pain relief ranged from 1 to 6 months. Repeat injections were necessary in several of the patients. There were minor complications but these reversed spontaneously without further treatment. 相似文献
1